Indian equity markets staged a measured rebound as benchmark indices Sensex and Nifty closed higher, supported by renewed buying in banking and metal stocks. After recent volatility, investors selectively returned to sectors viewed as closely tied to economic momentum and balance-sheet strength. Banking shares gained on expectations of steady credit growth and stable asset quality, while metal stocks benefited from improving demand signals and firmer global commodity trends.

IndusInd Bank has significantly expanded its gold loan footprint, increasing the number of dedicated branches offering the product to 500 across India. The move reflects the bank’s broader strategy to deepen its presence in secured retail lending while tapping into the enduring demand for gold-backed credit. As borrowers seek faster, collateral-based financing amid economic uncertainty, gold loans have emerged as a resilient and high-margin segment for banks.

As artificial intelligence becomes deeply embedded in enterprise operations, concerns around ethics and data privacy are moving to the center of corporate strategy. A senior executive at Salesforce has underscored the need for responsible AI development that prioritizes transparency, accountability and user trust alongside innovation. Speaking on the evolving regulatory and business landscape, the executive emphasized that ethical safeguards are no longer optional but essential to long-term value creation.

The launch of the Tata Punch EV marks a pivotal moment in India’s electric vehicle transition, signaling a decisive push toward mass-market electrification. Positioned at the entry level, the compact electric SUV blends affordability, practicality and credible driving range, challenging the perception that EVs remain a premium indulgence. Backed by Tata Motors’ expanding EV ecosystem, the Punch EV aims to bring electric mobility within reach of first-time buyers and urban commuters.

The convergence of artificial intelligence and biological intelligence is reshaping modern healthcare, redefining how diseases are diagnosed, treated and prevented. By combining machine learning systems with deep biological insights, healthcare providers are moving toward more precise, predictive and personalized care models. From early disease detection and drug discovery to robotic surgery and patient monitoring, AI-driven tools are augmenting clinical decision-making rather than replacing it.

Global semiconductor major Qualcomm and Indian conglomerate Tata Group have announced a strategic collaboration to manufacture advanced automotive modules in India, marking a significant step in the country’s push toward high-value electronics manufacturing. The partnership is aimed at developing and producing next-generation vehicle technologies, including connected, intelligent and software-defined automotive solutions.

India’s equity markets bounced back strongly, with benchmark indices reversing recent losses amid improved global cues and renewed domestic buying interest. The Sensex and Nifty 50 advanced in tandem, supported by gains in banking, metals and select technology stocks. Investors appeared encouraged by easing volatility, stable macro indicators and selective value buying after the recent correction.

Omnitech Engineering, a fast-growing precision engineering company, is set to enter India’s primary market with a Rs. 583 crore initial public offering opening on Feb. 25. The issue combines a fresh equity raise and a partial promoter sell-down, aimed at strengthening the balance sheet and funding expansion. Priced in the range of Rs. 216 to Rs. 227 per share, the IPO comes at a time when investor appetite for industrial and manufacturing stories remains selective but resilient.

India’s sugar exports have reached 2.01 lakh tonnes in the current marketing cycle, reflecting steady overseas demand despite tighter domestic supply conditions. The export performance comes at a time when policymakers are balancing global trade commitments with local price stability and food security considerations. Industry participants attribute the shipments to previously contracted volumes and calibrated export permissions. While the figure remains modest compared to peak export years, it signals India’s continued relevance in global sugar trade flows.

Pharmaceutical giant Zydus Lifesciences has launched a new biosimilar therapy targeting visual impairment, marking a significant advancement in ophthalmic care. The product offers an alternative to existing biologics, promising comparable efficacy at a more accessible cost, potentially reducing treatment expenditures for patients. Analysts view this launch as a strategic move to strengthen Zydus’s presence in the high-growth ophthalmology segment, which is witnessing rising demand due to aging populations and chronic eye conditions.